503 related articles for article (PubMed ID: 19451327)
1. Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria.
Agaba PA; Sule HM; Ojoh RO; Hassan Z; Apena L; Mu'azu MA; Badung B; Agbaji OO; Idoko JA; Kanki P
Int J STD AIDS; 2009 Jun; 20(6):410-3. PubMed ID: 19451327
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma in HIV-infected women and men in Nigeria.
Ibekwe PU; Ogunbiyi OA; Ogun GO; George OA
AIDS Patient Care STDS; 2011 Nov; 25(11):635-7. PubMed ID: 21967494
[TBL] [Abstract][Full Text] [Related]
3. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.
Lin CY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Lo YC; Hung CC; Chang SC
J Microbiol Immunol Infect; 2009 Jun; 42(3):227-33. PubMed ID: 19812856
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
6. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
[TBL] [Abstract][Full Text] [Related]
7. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of HIV-1-associated Kaposi's sarcoma among women and men in South Africa.
Mosam A; Hurkchand HP; Cassol E; Page T; Cassol S; Bodasing U; Aboobaker J; Dawood H; Friedland GH; Coovadia HM
Int J STD AIDS; 2008 Jun; 19(6):400-5. PubMed ID: 18595878
[TBL] [Abstract][Full Text] [Related]
9. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
10. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
[TBL] [Abstract][Full Text] [Related]
11. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
Mussini C; Manzardo C; Johnson M; Monforte Ad; Uberti-Foppa C; Antinori A; Gill MJ; Sighinolfi L; Borghi V; Lazzarin A; Miró JM; Sabin C;
AIDS; 2008 Nov; 22(18):2461-9. PubMed ID: 19005269
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).
Mani D; Neil N; Israel R; Aboulafia DM
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(5):279-85. PubMed ID: 19721098
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma in a hospital setting in Lomé (Togo): a study of 93 cases.
Pitche PT; Kombate K; Owono F; Tchangai-Walla K
Int J Dermatol; 2007 Oct; 46 Suppl 1():42-4. PubMed ID: 17919207
[TBL] [Abstract][Full Text] [Related]
14. AIDS-associated Kaposi's sarcoma in Northeastern Nigeria.
Kagu MB; Nggada HA; Garandawa HI; Askira BH; Durosinmi MA
Singapore Med J; 2006 Dec; 47(12):1069-74. PubMed ID: 17139404
[TBL] [Abstract][Full Text] [Related]
15. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma in Nigeria.
Onunu AN; Okoduwa C; Eze EU; Adeyekun AA; Kubeyinje EP; Schwartz RA
Int J Dermatol; 2007 Mar; 46(3):264-7. PubMed ID: 17343581
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow macrophage iron stores in patients with HIV infection and AIDS-associated Kaposi's sarcoma.
Kagu MB; Khalil MI; Ahmed SG
Afr J Med Med Sci; 2007 Jun; 36(2):125-8. PubMed ID: 19205574
[TBL] [Abstract][Full Text] [Related]
18. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea.
Oh MD; Park SW; Kim HB; Kim US; Kim NJ; Choi HJ; Shin DH; Lee JS; Choe K
Clin Infect Dis; 1999 Dec; 29(6):1524-8. PubMed ID: 10585807
[TBL] [Abstract][Full Text] [Related]
20. Trends in Kaposi's sarcoma survival disparities in the United States: 1980 through 2004.
Datta GD; Kawachi I; Delpierre C; Lang T; Grosclaude P
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2718-26. PubMed ID: 20861396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
